Trinitrotoluene (TNT) is a widely used explosive belonging to the family of nitroaromatic compounds, and its misuse poses a significant threat to society. Herein, we propose a Tb-BSA-AuNC fluorescent and colorimetric sensing probe for the selective onsite detection of TNT in the aqueous phase. Tb-doped BSA-protected gold nanoclusters (Tb-BSA-AuNCs) were synthesized by a microwave-assisted method, and TNT detection was carried out utilizing the chemistry of Meisenheimer complex formation. Tb doping of gold nanoclusters was demonstrated to facilitate better electron shuttling effects and thereby improve the efficiency of complex formation between the TNT and gold nanoclusters. A paper strip assay was also developed for TNT detection with the designed probe. Limits of detection and quantification of 0.2136 mM and 0.7120 mM, respectively, were achieved. Graphical abstract.
Exploring the interactions of a Tb(III)-quercetin complex with serum albumins (HSA and BSA): spectroscopic and molecular docking studies.
- Serum albumins (human serum albumin (HSA) and bovine serum albumin (BSA), two main circulatory proteins), are globular and monomeric macromolecules in plasma that transport many drugs and compounds. In the present study, we investigated the interactions of the Tb(III)-quercetin (Tb-QUE) complex with HSA and BSA using common spectroscopic techniques and a molecular docking study. Fluorescence data revealed that the inherent fluorescence emission of HSA and BSA was markedly quenched by the Tb-QUE complex through a static quenching mechanism, confirming stable complex formation (a ground-state association) between albumins and Tb-QUE.
- Binding and thermodynamic parameters were obtained from the fluorescence spectra and the related equations at different temperatures under biological conditions. The binding constants (Kb ) were calculated to be 0.8547 × 103 M-1 for HSA and 0.1363 × 103 M-1 for BSA at 298 K. Also, the number of binding sites (n) of the HSA/BSA-Tb-QUE systems was obtained to be approximately 1. Thermodynamic data calculations along with molecular docking results indicated that electrostatic interactions have a main role in the binding process of the Tb-QUE complex with HSA/BSA.
- Furthermore, molecular docking outputs revealed that the Tb-QUE complex has high affinity to bind to subdomain IIA of HSA and BSA. Binding distances (r) between HSA-Tb-QUE and BSA-Tb-QUE systems were also calculated using the Forster (fluorescence resonance energy transfer) method. It is expected that this study will provide a pathway for designing new compounds with multiple beneficial effects on human health from the phenolic compounds family such as the Tb-QUE complex.
BSA-AuNPs@Tb-AMP metal-organic frameworks for ratiometric fluorescence detection of DPA and Hg2.
An easy and effective strategy for synthesizing a ratiometric fluorescent nanosensor has been demonstrated in this work. Novel fluorescent BSA-AuNPs@Tb-AMP (BSA, bovine serum albumin; AMP, adenosine 5′-monophosphate; AuNPs, Au nanoparticles) metal-organic framework (MOF) nanostructures were synthesized by encapsulating BSA-AuNPs into Tb-AMP MOFs for the detection of 2,6-pyridinedicarboxylic acid (DPA) and Hg2+ . DPA could strongly co-ordinate with Tb3+ to replace water molecules from the Tb3+ center and accordingly enhanced the fluorescence of Tb-AMP MOFs. The fluorescence of BSA-AuNPs at 405 nm remained constant. While the fluorescence of BSA-AuNPs at 635 nm was quenched after Hg2+ was added, the fluorescence of Tb-AMP MOFs remained constant.
Accordingly, a ratiometric fluorescence nanosensor was constructed for detection of DPA and Hg2+ . The ratiometric nanosensor exhibited good selectivity to DPA over other substances. The F545 /F405 linearly increased with increase of DPA concentration in the range of 50 nM to 10 μM with a detection limit as low as 17.4 nM. F635 /F405 increased linearly with increase of Hg2+ concentration ranging from 50 nM to 1 μM with a detection limit as low as 20.9 nM. Additionally, the nanosensor could be successfully applied for the determination of DPA and Hg2+ in running water.
A novel ratiometric fluorescence nanosensor for superoxide anion (O2•- ) detection was designed with gold nanoparticles-bovine serum albumin (AuNPs-BSA)@terbium/guanosine monophosphate disodium (Tb/GMP) nanoscale coordination polymers (NCPs) (AuNPs-BSA@Tb/GMP NCPs). The abundant hydroxyl and amino groups of AuNPs-BSA acted as binding points for the self-assembly of Tb3+ and GMP to form core-shell AuNPs-BSA@Tb/GMP NCP nanosensors. The obtained probe exhibited the characteristic fluorescence emission of both AuNPs-BSA and Tb/GMP NCPs.
The AuNPs-BSA not only acted as a template to accelerate the growth of Tb/GMP NCPs, but also could be used as the reference fluorescence for the detection of O2•- . The resulting AuNPs-BSA@Tb/GMP NCP ratiometric fluorescence nanosensor for the detection of O2•- demonstrated high sensitivity and selectivity with a wide linear response range (14 nM-10 μM) and a low detection limit (4.7 nM).
Spectroscopic investigation on sonodynamic and sonocatalytic damage of BSA molecules by Thymol Blue (TB) derivants under ultrasonic irradiation.
In this paper, the Thymol Blue derivants including Thymol Blue (thymolsulfonphthalein), Thymol Blue-DA (3,3′-Bis [N,N-bis (carboxymethyl) aminomethyl] thymolsulfonphthalein) and Thymol Blue-DA-Fe(III) (3,3′-Bis [N,N-bis (carboxymethyl) aminomethyl] thymolsulfonphthalein-Ferrous(III)) were adopted as sonosensitizers to study the sonodynamic and sonocatalytic activities under ultrasonic irradiation. At first, the interaction of Thymol Blue derivants with bovine serum albumin (BSA) was studied by fluorescence spectroscopy. On that basis, the sonodynamic and sonocatalytic damages of Thymol Blue derivants to BSA under ultrasonic irradiation were investigated by the combination of UV-vis, circular dichroism (CD) and fluorescence spectroscopy. Meanwhile, some influenced factors (ultrasonic irradiation time, Thymol Blue derivants concentration and ionic strength) on the damaging degree of BSA molecules were also reviewed.
In addition, synchronous fluorescence spectra were used to estimate the binding and damage sites of Thymol Blue derivants to BSA. Finally, the generation of ROS during sonodynamic and sonocatalytic processes was confirmed by the method of Oxidation-Extraction Spectrometry (OEP). Perhaps, this paper may offer some important subjects for the study of Thymol Blue derivants in sonodynamic therapy (SDT) and sonocatalytic therapy (SCT) technologies for tumor treatment and the effect of the amino acid and central metal.
BSA (10%) in TBS, Sterile |
|||
21420069-1 | Glycomatrix | 100 mL | 46.6 EUR |
BSA (10%) in TBS, Sterile |
|||
21420069-2 | Glycomatrix | 500 mL | 155.56 EUR |
TBS blocking buffer with BSA |
|||
SD8113 | Bio Basic | 1pk, 1L | 100.72 EUR |
TBS Buffer with 5% BSA, Sterile |
|||
40121077-1 | Glycomatrix | 100 mL | 28 EUR |
TBS Buffer with 5% BSA, Sterile |
|||
40121077-2 | Glycomatrix | 500 mL | 77.39 EUR |
TBS Buffer with 5% BSA, Sterile |
|||
40121077-3 | Glycomatrix | 1 L | 146.87 EUR |
TBS Buffer with 11% BSA, Sterile |
|||
40121080-1 | Glycomatrix | 100 mL | 40.35 EUR |
TBS Buffer with 11% BSA, Sterile |
|||
40121080-2 | Glycomatrix | 500 mL | 130.95 EUR |
TBS Buffer with 11% BSA, Sterile |
|||
40121080-3 | Glycomatrix | 1 L | 235.31 EUR |
BSA (1%) in TBS pH 8.0, Powder |
|||
40120437-1 | Bio-WORLD | 10 PK (s) | Ask for price |
BSA (3%) Blocking Buffer 1X in TBS |
|||
40220095-1 | Glycomatrix | 100 mL | 30.47 EUR |
BSA (3%) Blocking Buffer 1X in TBS |
|||
40220095-2 | Glycomatrix | 250 mL | 44.66 EUR |
BSA (3%) Blocking Buffer 1X in TBS |
|||
40220095-3 | Glycomatrix | 1 L | 77.39 EUR |
BSA (10%) Blocking Buffer in 10X TBS, pH 7.4 |
|||
40220068-1 | Glycomatrix | 100 mL | 48.59 EUR |
BSA (10%) Blocking Buffer in 10X TBS, pH 7.4 |
|||
40220068-2 | Glycomatrix | 200 mL | 89.77 EUR |
BSA (10%) Blocking Buffer in 10X TBS, pH 7.4 |
|||
40220068-3 | Glycomatrix | 500 mL | 149.25 EUR |
BSA (3%) Blocking Buffer 1X in TBS and Tween 20 |
|||
21420074-1 | Glycomatrix | 250 ml | 31.87 EUR |
BSA (3%) Blocking Buffer 1X in TBS and Tween 20 |
|||
21420074-2 | Glycomatrix | 500 mL | 52.91 EUR |
BSA (3%) Blocking Buffer 1X in TBS and Tween 20 |
|||
21420074-3 | Glycomatrix | 1 L | 77.39 EUR |
TBS |
|||
I004 | Cygnus Technologies | 1000 ml | 262.8 EUR |
TBS, 20X |
|||
18-236 | Genesee Scientific | 500ml/Unit | 54.33 EUR |
TBS, 20X |
|||
18-236B | Genesee Scientific | 1000ml/Unit | 91.8 EUR |
TBS Packs |
|||
40220088-1 | Glycomatrix | 10 PK(s) | 42.58 EUR |
TBS Packs |
|||
40220088-2 | Glycomatrix | 40 PK(s) | 102.65 EUR |
TBS(powder) |
|||
EZWB22-S-2L | Shanghai WSHT Biotechnology | 2L | 1.2 EUR |
TBS Buffer |
|||
AR0031 | Antagene | 2000ml/pouch | 55 EUR |
TBS, pH7.4, 10× |
|||
EZWB22-1-10x | Shanghai WSHT Biotechnology | 500mL | 7.2 EUR |
TBS, pH7.4, 1× |
|||
EZWB22-1-1x | Shanghai WSHT Biotechnology | 500mL | 4.8 EUR |
[Luminescence properties of rare earth complexes Tb(BSA)4].
A new rare earth complex Tb(BSA)4 was synthesized and studied. Pure green and narrow band emission was generated from the device with structure ITO/PVK:Tb(BSA)4 /Alq3 /LiF/Al, where PVK was used to improve the film-formation and hole-transport property of the Tb(BSA)4. The absorption mechanism, and the photoluminescence and electroluminescence mechanisms are discussed. It has been proved that there exists energy transfer from PVK to Tb(BSA)4 and the mechanisms of photoluminescence and electroluminescence are different. The effect of different ratios of PVK on the device characteristics is also studied.